Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
Recruiting · NCT04318717 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma | Mucosal Melanoma of the Head and Neck | Recruiting | Phase 2 | 2026-08-27 | NCT04318717 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Washington University School of Medicine | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University School of Medicine | St Louis | United States | 895 |